Provided by Tiger Trade Technology Pte. Ltd.

AstraZeneca PLC

162.13
-0.5700-0.35%
Post-market: 163.000.8700+0.54%19:51 EDT
Volume:3.07M
Turnover:498.51M
Market Cap:251.46B
PE:24.27
High:163.75
Open:162.70
Low:161.95
Close:162.70
52wk High:212.71
52wk Low:145.79
Shares:1.55B
Float Shares:1.50B
Volume Ratio:1.07
T/O Rate:0.20%
Dividend:3.23
Dividend Rate:1.99%
EPS(TTM):6.68
EPS(LYR):6.54
ROE:21.96%
ROA:8.02%
PB:5.00
PE(LYR):24.79

Loading ...

Guggenheim Keeps Their Buy Rating on AstraZeneca (AZN)

TIPRANKS
·
Jul 10

CSPC Pharma Receives $25 Million R&D Milestone Payment from AstraZeneca Under Strategic Collaboration and Licensing Deal

Stock News
·
Jul 10

Movement Alert|AstraZeneca Falls 3.11% in Regular Trading, Continued Selloff Following Wainua Phase 3 Clinical Trial Failure

Market Focus
·
Jul 10

AstraZeneca (AZN) Receives a Buy from Citi

TIPRANKS
·
Jul 10

US Appeals Court Upholds Win for Astrazeneca in Pfizer Cancer Drug Patent Fight

Reuters
·
Jul 10

Appeals court upholds win for AstraZeneca in Pfizer patent fight, Reuters says

TIPRANKS
·
Jul 10

Top Midday Decliners

MT Newswires Live
·
Jul 10

European Markets Rebound as Tech and Mining Stocks Advance; AstraZeneca Plummets

Deep News
·
Jul 10

Alnylam, Bridgebio Gain from Astrazeneca-ionis Drug Missing Target

Dow Jones
·
Jul 10

Astrazeneca Slips Thursday, Underperforms Market

Dow Jones
·
Jul 10

Top Midday Stories: Tensions Rise as US, Iran Trade Attacks; Micron to Invest $3 Billion in US Semiconductor Supply Chain

MT Newswires Live
·
Jul 09

AstraZeneca PLC Stock (AZN) Moved Down by 6.72% on Jul 9: A Full Analysis

TradingKey
·
Jul 09

Bernstein Sticks to Its Buy Rating for AstraZeneca (AZN)

TIPRANKS
·
Jul 09

Is AstraZeneca (AZN) Stock a Buy on Today’s Dip? Here’s What Analysts Have to Say About That

TIPRANKS
·
Jul 09

Movement Alert|AstraZeneca Falls 7.83% in Regular Trading, Heart Disease Drug Wainua Fails to Meet Primary Endpoint in Phase 3 Trial

Market Focus
·
Jul 09

Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Thursday as Chip Stocks Rebound Despite US-Iran Tensions

MT Newswires Live
·
Jul 09

Astrazeneca and Ionis Stocks Sink on Trial Miss and Analysts See an Overreaction

Dow Jones
·
Jul 09

Ionis Pharmaceuticals Shares Sink After Late-stage Trial Failed to Meet Primary Goal

Dow Jones
·
Jul 09

Schwab Strategists Warn of a Major Market Shift: the Era of Easy Index Gains is Officially Over.

Dow Jones
·
Jul 09

AstraZeneca (AZN) Gets a Buy from Jefferies

TIPRANKS
·
Jul 09